Loading...
Profile of glycopyrronium for once-daily treatment of moderate-to-severe COPD
Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). Long-acting muscarinic antagonists (LAMAs) and long-acting β(2)-agonists (LABAs) are the main classes of long-acting bronchodilators. To date, tiotropium is the only once-daily LAMA available f...
Na minha lista:
| Main Authors: | , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
Dove Medical Press
2012
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3484531/ https://ncbi.nlm.nih.gov/pubmed/23118536 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/COPD.S36001 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|